Critical role for casein kinase 2 and phosphoinositide-3-kinase in the interferon-gamma-induced expression of monocyte chemoattractant protein-1 and other key genes implicated in atherosclerosis

Arterioscler Thromb Vasc Biol. 2007 Apr;27(4):806-12. doi: 10.1161/01.ATV.0000258867.79411.96. Epub 2007 Jan 25.

Abstract

Objective: The interferon-gamma (IFN-gamma)-mediated regulation of macrophage gene expression is of crucial importance in the pathogenesis of atherosclerosis. The mechanisms underlying the actions of IFN-gamma signaling in macrophages were investigated using monocyte chemoattractant protein (MCP)-1 as a model gene.

Methods and results: The IFN-gamma-induced expression of MCP-1 in macrophages was attenuated by inhibitors of phosphoinositide-3-kinase (PI3K), casein kinase 2 (CK2), and Janus kinase (JAK)-2. AKT was the downstream target for PI3K action. Electrophoretic mobility shift assays and chromatin immunoprecipitation showed that signal transducer and activator of transcription (STAT)-1 interacted with IFN-gamma responsive elements in the MCP-1 gene promoter. The IFN-gamma-induced activity of the MCP-1 gene promoter and an artificial promoter containing STAT1 responsive elements was inhibited by expression of dominant negative forms of JAK-1 and -2, STAT1, CK2, and AKT. The action of CK2 and AKT on STAT1 activation was mediated, at least in part, through the regulation of serine 727 phosphorylation. Analysis of a number of other genes regulated by this cytokine and implicated in atherosclerosis revealed a gene-specific action for PI3K/AKT in IFN-gamma signaling.

Conclusions: These studies provide novel insights into the role of PI3K/AKT and CK2 in IFN-gamma signaling relevant to changes in macrophage gene expression during atherosclerosis.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Atherosclerosis / genetics
  • Atherosclerosis / metabolism*
  • Casein Kinase II / antagonists & inhibitors
  • Casein Kinase II / metabolism*
  • Cell Line
  • Chemokine CCL2 / genetics
  • Chemokine CCL2 / metabolism*
  • Gene Expression Regulation
  • Humans
  • Interferon-gamma / pharmacology*
  • Janus Kinases / metabolism
  • Macrophages / metabolism*
  • Mice
  • Phosphatidylinositol 3-Kinases / metabolism*
  • Phosphoinositide-3 Kinase Inhibitors
  • Protein Kinase Inhibitors / pharmacology
  • Proto-Oncogene Proteins c-akt / metabolism
  • STAT1 Transcription Factor / metabolism
  • Signal Transduction

Substances

  • Chemokine CCL2
  • Phosphoinositide-3 Kinase Inhibitors
  • Protein Kinase Inhibitors
  • STAT1 Transcription Factor
  • Interferon-gamma
  • Janus Kinases
  • Casein Kinase II
  • Proto-Oncogene Proteins c-akt